BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications

| March 23, 2015 | 0 Comments

NEW YORK — BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of …

Taken from:
BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications

Tags: , , , , , , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply